Grow together, create impact, faster.

Bridging longevity science, precision health, and retail innovation to build what actually works.

01
Introduction

25 years turning complex science into businesses people can actually use.

Most longevity experts stay in the lab. Most retail operators never touch the science. I do both. My work lives at the intersection of precision medicine and consumer health, where cutting edge genomics meets the front door of your neighborhood wellness clinic.

I’ve built companies in personal genomics, launched IV therapy networks, mentored over 40 hardware startups from idea to shelf, and yes, once ran a five star hotel in Sicily that offered DNA testing to every guest. Some called it eccentric. The guests called it ahead of its time.

Today, I invest in and advise businesses that bring longevity science to real people. Not just the ones who can afford private physicians. Everyone.

02
Publications

Writing that bridges science and practice

The final volume in a trilogy exploring the future of predictive medicine. Co authored with Paolo Marandola and Nicola Locorotondo, this book maps how technology, biology, and genomics converge with the digital world to create medicine that prevents rather than cures. A journey between present and future written for anyone who believes healthcare should predict problems, not just treat them.

Publisher: Aracne Editrice, 2016

The final volume in a trilogy exploring the future of predictive medicine. Co authored with Paolo Marandola and Nicola Locorotondo, this book maps how technology, biology, and genomics converge with the digital world to create medicine that prevents rather than cures. A journey between present and future written for anyone who believes healthcare should predict problems, not just treat them.

Publisher: Aracne Editrice, 2016

Published with Mondadori, this manifesto explores the cultural and scientific revolution transforming medicine from purely therapeutic to genuinely predictive. The book asks a fundamental question: if our DNA suggests we could live to 120, should we? And more importantly, how do we live those years with clarity of thought and physical independence?

Publisher: Mondadori, Sperling & Kupfer, 2010
03
About

Taking Science Personally

Ivan Marandola builds businesses at the intersection of longevity science and consumer health. As Chairman of Reviv Italy and Chief Intuition Officer at PRCNX Fund, he invests in precision medicine, IV therapy, and retail health ventures that bring cutting edge science to everyday people. His career spans genomics (YourLife, Fly Life), retail tech (iWaboo, 500 Startups Batch 15), and luxury hospitality (Kempinski Hotel Sicily). He’s authored two books on predictive medicine, raised over €65 million across ventures, and mentors startups at Boomtown and Brinc.io. Harvard Business School. Made in Zambia. Forged in the US. Lost in Italy.

Trusted by leading brands worldwide

Image gallery marquee
Image gallery marquee
Image gallery marquee
Image gallery marquee
Image gallery marquee
Image gallery marquee
Image gallery marquee
Image gallery marquee
Image gallery marquee
Image gallery marquee
Image gallery marquee
04
Events

Writing that bridges science and practice

REVIVME 2025 Event

REVIVME 2025

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in

Molecular Club

Molecules Connect, So Do We.

Step into a collective of like-minded explorers, thinkers, and changemakers. Our society is built on purpose, shared values, and the pursuit of extraordinary experiences that connect us to something greater.

Credit: Dr. Kasia Redman | Shot: Bellecell clinic

05
Articles

Thoughts on longevity, retail health, and building what matters

Regular dispatches from the front lines of precision medicine, healthspan economics, and the occasionally absurd world of biohacking.